BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER
Clinical trials for BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER explained in plain language.
Never miss a new study
Get alerted when new BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER trials appear
Sign up with your email to follow new studies for BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New liquid biopsy could catch bladder cancer recurrence early
Diagnosis Recruiting nowThis study is testing whether a simple blood or urine test (called a liquid biopsy) can help find, monitor, and predict the return of urothelial carcinoma, a type of bladder cancer. Researchers will compare these test results with standard tissue biopsies in 300 people who have o…
Matched conditions: BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER
Sponsor: Tianjin Medical University Second Hospital • Aim: Diagnosis
Last updated May 13, 2026 16:03 UTC
-
Personalized program aims to reduce frailty in older cancer patients
Symptom relief Recruiting nowThis study tests a 6-month personalized program for older adults being treated for bladder or kidney cancer. The program includes exercise, education, and support before and after surgery. Researchers want to see if it helps reduce frailty and improve recovery. The study will enr…
Matched conditions: BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC
-
New gene test could spot tough-to-treat tumours and boost radiation success
Knowledge-focused Recruiting nowThis study aims to prove that a gene test can identify oxygen-starved (hypoxic) tumours in real time for bladder and prostate cancer patients. About 30 participants will provide tumour samples and blood, plus undergo MRI scans. If successful, doctors could tailor stronger treatme…
Matched conditions: BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER
Sponsor: University of Manchester • Aim: Knowledge-focused
Last updated May 17, 2026 04:33 UTC